Why the study?
Remote monitoring has potential to improve care and optimize therapy to prevent heart failure admissions, but its clinical and economic consequences in patients with CIEDs needed assessment.
Does remote monitoring reduce mortality, cardiovascular hospitalizations, and direct costs compared to standard monitoring in patients with cardiac implantable electronic devices?
Does remote monitoring reduce mortality, cardiovascular hospitalizations, and direct costs compared to standard monitoring in patients with cardiac implantable electronic devices?
Remote monitoring of patients with CIEDs is associated with significantly improved 2-year survival, reduced cardiovascular hospitalizations, and substantial cost savings compared to standard in-office monitoring.
No takes yet. Share an insight, caveat, or question.
Supports remote monitoring benefits in CIED patients; hypothesis-generating and should not yet change practice pending RCTs.
Marini et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: